Abstract
Purpose
Acute exacerbations (AE) in patients with COPD are associated with a decline in lung function, increased risk of hospitalization, and mortality. In this cross-sectional study we tested whether the level of objectively measured daily physical activity and exercise capacity are associated with the number of COPD exacerbations.
Methods
In 210 patients with COPD (67 % men; mean (SD) age: 63 (8) years) enrolled in The Obstructive Pulmonary Disease Outcomes Cohort of Switzerland (TOPDOCS) physical activity (PA) (steps per day, physical activity level, (PAL)), exercise capacity (6-min walking distance, (6MWD)), comorbidities, lung function, and medication were assessed. Differences between COPD patients with frequent (≥2 year) and infrequent (0–1 year) exacerbations were assessed. Univariate and multivariate analyses were performed to investigate whether the level of objectively measured daily physical activity and exercise capacity are associated with the number of COPD exacerbations.
Results
Patients with frequent AE had a significantly lower FEV1 and 6MWD compared to patients with infrequent AE. In univariate analysis, the number of exacerbations was inversely associated with FEV1, 6MWD, BMI, and smoking status while there was a positive association with RV/TLC and combined inhaled medication. However, there was no significant association with PAL and steps per day. In multivariate analysis, FEV1 and the use of combined inhaled medication were independently associated with the number of AE, after correction for covariates.
Conclusions
The findings of this study imply that FEV1, independent of inhaled medication, is significantly associated with COPD exacerbations. Neither physical activity nor exercise capacity was independently associated with COPD exacerbations.
Similar content being viewed by others
References
Donaldson GC, Wedzicha JA (2006) COPD exacerbations.1: epidemiology. Thorax 61(2):164–168
Rabe KF, Hurd S, Anzueto A et al (2007) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176(6):532–555
Hurst JR, Vestbo J, Anzueto A et al (2010) Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363(12):1128–1138
Anzueto A, Leimer I, Kesten S (2009) Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes. Int J Chronic Obstr Pulm Dis 4:245–251
Kanner RE, Anthonisen NR, Connett JE (2001) Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 164(3):358–364
Cote CG, Dordelly LJ, Celli BR (2007) Impact of COPD exacerbations on patient-centered outcomes. Chest 131(3):696–704
Vestbo J, Edwards LD, Scanlon PD et al (2011) Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 365(13):1184–1192
Agusti A, Calverley PM, Celli B et al (2010) Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 11:122
Seemungal TA, Donaldson GC, Paul EA et al (1998) Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157(5 Pt 1):1418–1422
Connors AF Jr., Dawson NV, Thomas C et al (1996) Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (study to understand prognoses and preferences for outcomes and risks of treatments). Am J Respir Crit Care Med 154(4 Pt 1):67–959
Gunen H, Hacievliyagil SS, Kosar F et al (2005) Factors affecting survival of hospitalised patients with COPD. Eur Respir J 26(2):234–241
Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P et al (2005) Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60(11):925–931
Garcia-Rio F, Rojo B, Casitas R et al (2012) Prognostic value of the objective measurement of daily physical activity in COPD patients. Chest 142(2):338–346
Garcia-Aymerich J, Lange P, Benet M et al (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61(9):772–778
Garcia-Aymerich J, Serra I, Gomez FP et al (2009) Physical activity and clinical and functional status in COPD. Chest 136(1):62–70
Casaburi R (2011) Activity promotion: a paradigm shift for chronic obstructive pulmonary disease therapeutics. Proc Am Thorac Soc 8(4):334–337
Garcia-Aymerich J, Farrero E, Felez MA et al (2003) Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 58(2):100–105
Seidel D, Cheung A, Suh ES et al (2012) Physical inactivity and risk of hospitalisation for chronic obstructive pulmonary disease. Int J Tuberc Lung Dis 16(8):1015–1019
Donaldson GC, Wilkinson TM, Hurst JR et al (2005) Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171(5):446–452
Lichtman SW, Pisarska K, Berman ER et al (1992) Discrepancy between self-reported and actual caloric-intake and exercise in obese subjects. N Engl J Med 327(27):1893–1898
van Gestel AJ, Clarenbach CF, Stowhas AC et al (2012) Predicting daily physical activity in patients with chronic obstructive pulmonary disease. PLoS One 7(11):e48081
Waschki B, Spruit MA, Watz H et al (2012) Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med 106(4):522–530
Manini TM, Everhart JE, Patel KV et al (2006) Daily activity energy expenditure and mortality among older adults. JAMA 296(2):171–179
Scheers T, Philippaerts R, Lefevre J (2012) Assessment of physical activity and inactivity in multiple domains of daily life: a comparison between a computerized questionnaire and the SenseWear armband complemented with an electronic diary. Int J Behav Nutr Phys Act 9(1):71
ATS (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166(1):111–117
Laurent S, Boutouyrie P, Asmar R et al (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37(5):1236–1241
Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26(2):319–338
Boon RM, Hamlin MJ, Steel GD et al (2010) Validation of the New Zealand physical activity questionnaire (NZPAQ-LF) and the international physical activity questionnaire (IPAQ-LF) with accelerometry. Br J Sports Med 44(10):741–746
Ekelund U, Sepp H, Brage S et al (2006) Criterion-related validity of the last 7-day, short form of the international physical activity questionnaire in Swedish adults. Public Health Nutr 9(2):258–265
Watz H, Waschki B, Meyer T et al (2009) Physical activity in patients with COPD. Eur Respir J 33(2):262–272
Carr SJ, Goldstein RS, Brooks D (2007) Acute exacerbations of COPD in subjects completing pulmonary rehabilitation. Chest 132(1):127–134
McAllister DA, Maclay JD, Mills NL et al (2007) Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 176(12):1208–1214
Blacher J, Guerin AP, Pannier B et al (1999) Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99(18):2434–2439
Conflict of interest
There are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
M. Schönmann and N.A. Sievi shared first authorship.
Rights and permissions
About this article
Cite this article
Schönmann, M., Sievi, N.A., Clarenbach, C.F. et al. Physical Activity and the Frequency of Acute Exacerbations in Patients with Chronic Obstructive Pulmonary Disease. Lung 193, 63–70 (2015). https://doi.org/10.1007/s00408-014-9673-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-014-9673-7